Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs
Open Access
- 22 November 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 88 (6) , 977-985
Abstract
Retinoic acid therapy improves the survival of children with neuroblastoma and 13‐cis retinoic acid now forms an important component of treatment for residual disease of stage IV neuroblastoma after chemotherapy. However, although 13‐cis retinoic acid induces differentiation, other retinoids are effective at inducing apoptosis of neuroblastoma in vitro, including the novel compounds fenretinide and CD437 and these may be alternative retinoids for neuroblastoma therapy. The aim of our study was to evaluate the ability of fenretinide, CD437 (6‐{3‐(1‐adamantyl)‐4‐hydroxyphenyl} ‐2‐naphthalene carboxylic acid) and different retinoic acid isomers to induce apoptosis of neuroblastoma in conjunction with the chemotherapeutic drugs, cisplatin, etoposide and carboplatin. Neuroblastoma cell lines were treated with retinoids prior to treatment with chemotherapeutic agents and flow cytometry used to measure apoptosis and free radical generation. Pre‐treatment of neuroblastoma cell lines with fenretinide or CD437 prior to treatment with cisplatin, etoposide or carboplatin synergistically increased apoptosis, an effect not seen with 13‐cis, all‐trans or 9‐cis retinoic acid. Contrary to retinoic acid isomers or chemotherapeutic drugs, apoptosis of neuroblastoma cells induced by fenretinide or CD437 was accompanied by the generation of intracellular free radicals. Quenching of fenretinide‐ or CD437‐induced free radicals with antioxidants abolished the synergistic response seen with the subsequent addition of chemotherapeutic agents. Therefore, the generation of free radicals by fenretinide or CD437 may be the key property of these retinoids leading to synergistic responses with chemotherapeutic drugs. Clearly, these synthetic retinoids provide new opportunities for novel neuroblastoma therapy. Int. J. Cancer 88:977–985, 2000.Keywords
This publication has 22 references indexed in Scilit:
- Increased Expression of Death Receptors 4 and 5 Synergizes the Apoptosis Response to Combined Treatment with Etoposide and TRAILMolecular and Cellular Biology, 2000
- CombiTool—A New Computer Program for Analyzing Combination Experiments with Biologically Active AgentsComputers and Biomedical Research, 1999
- The RARγ selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosisCancer Letters, 1999
- Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3The Prostate, 1999
- Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cellsBritish Journal of Cancer, 1998
- Apoptotic Effects of Different Drugs on Cultured Retinoblastoma Y79 CellsTumor Biology, 1998
- Role of antioxidants and intracellular free radicals in retinamide- induced cell deathCarcinogenesis, 1997
- Apoptosis of N-Type Neuroblastoma Cells After Differentiation With 9-cis-Retinoic Acid and Subsequent WashoutJNCI: Journal of the National Cancer Institute, 1997
- A rapid cell membrane permeability test using flourescent dyes and flow cytometryCell Biology and Toxicology, 1986
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984